ProductsBack/Mouse anti Human p21 WAF-1

Mouse anti Human p21 WAF-1

Name: Mouse anti Human p21 WAF-1
SKU: X1158M_100ug_N38
Availability: BackOrder

X1158M

ApplicationsWestern Blot, ELISA

Product group Antibodies

ReactivityHuman

TargetCDKN1A

Overview

Supplier
Nordic-MUbio
Product Name
Mouse anti Human p21 WAF-1
Delivery Days Customer
7
Application Supplier Note
Detects p21 protein by Western blot at 1 to 10 microg/ml. Detects a 21 kDa protein in MCF7 cells. Can be used with either frozen or paraffin embedded tissue sections. Optimal concentration should be evaluated by serial dilutions. Other Applications: ELISA
Applications
Western Blot, ELISA
Applications Supplier
Western Blotting;ELISA;Western Blotting
Category Supplier
Primary antibodies
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
WA-1
Conjugate
Unconjugated
Gene ID1026
Target name
CDKN1A
Target description
cyclin dependent kinase inhibitor 1A
Target synonyms
CAP20; CDK-interacting protein 1; CDK-interaction protein 1; CDKN1; CIP1; cyclin-dependent kinase inhibitor 1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); DNA synthesis inhibitor; MDA-6; melanoma differentiation associated protein 6; P21; p21CIP1; SDI1; WAF1; wild-type p53-activated fragment 1
Host
Mouse
Isotype
IgG1
Protein IDP38936
Protein Name
Cyclin-dependent kinase inhibitor 1
Shelf life instruction
See expiration date on vial
Reactivity
Human
Reactivity Supplier
Human
Reactivity Supplier Note
Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with human p21 protein and mouse myeloma SP2 cells.
UNSPSC
12352203

1. Hellin, A.C., et al. Roles of Nuclear Factor-kappaB, p53 and p21/WAF1 in Daunomycin-induced cell cycle arrest and apoptosis. J. Pharmacol. Exp. Ther. 2000, 295, 870-878 2. El-Deiry, W.S., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75, 817-825 3. Xiong, Y., et al. p21 is a universal inhibitor of cyclin kinases. Nature (Lond) 1993, 366, 701-704 4. Zhang, H., et al. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 1993, 4, 897-906 5. Kovalic, J., et al. Int. J. Oncol. 1996, 9 (suppl.), 835 6. Shen, J., et al. ‘Identification and Validation of Differences in Protein Levels in Normal, Premalignant, and Malignant Lung Cells and Tissues Using High-Throughput Western Array and Immunohistochemistry.’ Cancer Res., 66, 11194-11206 (2006).